It has proven to be a breakthrough drug in tackling coronavirus, but who manufactures dexamethasone and what is its brand name?

Over recent months, many lives have been lost to COVID-19 and the pandemic has altered all of our lives significantly.

Here in the UK, Boris Johnson announced lockdown measures back in March, informing the public only to go to work if absolutely necessary, shopping for essentials as infrequently as possible and brief exercise.

Since then, measures have been somewhat revised, but the threat looming over is still very much frightening.

All eyes and ears have been on the news in hopes of effective treatment being announced.

Fortunately, there is finally some good news….

Anthony Devlin/Getty Images

Coronavirus study shows benefits of dexamethasone

Dexamethasone is a low-cost corticosteroid which has proven to reduce deaths in COVID-19 patients, CNBC TV18 highlights.

Over at Oxford University, a study found that it may help reduce deaths by up to a third, with low-dosage displaying noteworthy benefits. As part of the trials, 2,104 patients received 6 mg once per day for ten days, with the results held in comparison to 4,321 in regular care.

The mortality rate in patients needing ventilation fell from 41% to 28%. Additionally, with patients who required only oxygen support, deaths were reduced by a fifth. 25% of oxygen support patients died on standard care, but only 20% died when on dexamethasone.

More information regarding dexamethasone’s effectiveness is being awaited.

Who manufactures dexamethasone? Brand name

As highlighted by the patient leaflet on Medicines.org, the manufacturer included is Aspen Bad Oldesloe GmbH, 32-36 Industriestrasse, 23843 Bad Oldesloe, Germany.

Although, there are different manufacturers and also a number of trade names it goes under, which Chemocare writes are Decadron, Dexasone, Diodex, Hexadrol and Maxidex.

Of course, the real concern for the UK public is whether there’s enough to go around.

Market Watch includes that Boris Johnson has described the recent study results as the “biggest breakthrough yet” against coronavirus. More importantly, he addressed that the U.K. has enough supplies of the drug in the chance of a second spike in hospital admissions.

Indeed, the earlier source also noted that the UK had already begun stockpiling the drug.

Trial investigator weighs in

CNBC TV18 included word from one of the trial’s chief investigators, Peter Horby – Professor of Emerging Infectious Diseases in the Nuffield Department of Medicine at theUniversity of Oxford – expressing:

“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients.”

An undeniable breakthrough.

In other news, is Blue Bloods cancelled?